| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |